Tech Meridian
← ENTITY INDEX
COMPANY · ENTITY #5057
Related event timeline, sources and context from the news index.
OpenAI is acquiring Orchestra Bio to integrate AI-powered operations into life‑sciences R&D, aiming to help biopharma teams accelerate drug development and advance new treatments. The move positions OpenAI to extend its AI capabilities into laboratory and research workflows in the life‑sciences sector.
Anthropic told Reuters it operates a wet biology lab where it can use its AI models to run physical experiments, and said the facility does some internal research while collaborating with external partners. The company — which acquired Coefficient Bio in April — declined to detail the lab’s projects, said it is not focused on drug discovery, and launched a Life Sciences Verification Program to give vetted researchers access to its most powerful models.
Allow Google Analytics to measure visits? It stays off until you choose. You can change your choice at any time.